The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia

Risk factors for relapse and non-relapse mortality (NRM) in the first years after allogeneic hematopoietic stem cells transplant (allo-HSCT) for acute myeloid leukemia (AML) are well known, but their correlation with long-term survivorship is unclear. This study aims to evaluate factors that impact...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alessandro Bruno, Francesca Lorentino, Matteo G. Carrabba, Sara Mastaglio, Raffaella Greco, Sarah Marktel, Simona Piemontese, Magda Marcatti, Luca Vago, Francesca Farina, Daniela Clerici, Elisa Diral, Lorenzo Lazzari, Edoardo Campodonico, Daniele Sannipoli, Andrea Assanelli, Consuelo Corti, Massimo Bernardi, Jacopo Peccatori, Fabio Ciceri, Maria Teresa Lupo-Stanghellini
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2026-05-01
סדרה:	Frontiers in Immunology
נושאים:	allogeneic stem cell transplantation (allo-SCT) AML - acute myeloid leukemia disease status at transplantation long term survivorship overall survival
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1818603/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!